Active · per the CBE, 28 September 2026

DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH

BE0766541015

Rechtspersoon Europees economisch samenwerkingsverband

DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH is an IT company in Brussel. Europees economisch samenwerkingsverband, started on 9 April 2021.

Egmontstraat 11, 1000 Brussel

Active for

5 year, 5 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Busy address KBO

    78 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH from Brussel, company number BE0766541015, closed financial year 2025 with a result of € 4,584 after tax. For that financial year DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH recorded a gross margin of € 75,556 and equity of € 0. Compared with financial year 2024, the result moved from € -499,647 to € 4,584. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.

What it is worth Caution

€ 0

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 4,584

▲ still € 499,647 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 3.6 million

▼ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 4,584 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 72,284

▼ 82% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 22,369

▼ 23% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 356,959 € 160,531 € -420,904 € 75,556 ▲ € 496,460
Profit after taxes € 356,055 € 133,642 € -499,647 € 4,584 ▲ € 504,231
Equity € 369,853 € 503,495 € 0 € 0
Total debts € 9,151 € 6,934,282 € 8,015,782 € 6,522,338 ▼ 19%
Cash € 70,575 € 6,536,926 € 4,621,535 € 3,627,187 ▼ 22%
Retained profit € 369,853 € 503,495 € 0 € 0
Dividend € 0 € 0 € 3,848 € 4,584 ▲ 19%
Balance sheet total € 379,004 € 7,437,777 € 8,015,782 € 6,522,338 ▼ 19%

Key figures of DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH?

What happened at DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Cathy Mary ENRIGHT stepped down as director. NBB
  • Aslaug HELLAND stepped down as director. NBB
  • Alessandro SGAMBATO stepped down as director. NBB
  • Xose Maria FERNANDEZ stepped down as director. NBB
  • Amaury MARTIN stepped down as director. NBB
  • Giovanni TONON stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 4,584. Source: NBB ↗
  • Cathy Mary ENRIGHT became a director. NBB

In short

From € 356,055 profit in 2022 to € 4,584 profit in 2025.

Best year ever: 2022, with € 356,055 profit.

Paid out € 8,432 in dividends to the owners in total.

Management

Directors

According to the 2025 annual accounts

Cathy Mary ENRIGHT

Trésorier

since 2025 · until 2028

Alessandro SGAMBATO

Director

since 2024 · until 2027

Xose Maria FERNANDEZ

Director

since 2024 · until 2027

Aslaug HELLAND

Director

since 2024 · until 2028

Amaury MARTIN

Director

since 2024 · until 2027

Giovanni TONON

Chairman of the board

since 2024 · until 2027

Establishments

Establishment units

Physical locations of this company

Registered office

Egmontstraat 11

1000 Brussel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0766.541.015
VAT number
BE 0766.541.015
Registered office
Egmontstraat 11, 1000 Brussel
Names & denominations
DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH
Enterprise type
Rechtspersoon
Legal form
Europees economisch samenwerkingsverband
Legal situation
Normale toestand
Start date
9 April 2021
Peppol
Active · Active since 18 Dec 2025
Activities · NACE

Ontwerpen van computerprogramma’s

Ontwerpen en programmeren van computerprogramma's

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Frequently asked questions

What does DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH do?
DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH is an IT company in Brussel. Europees economisch samenwerkingsverband, started on 9 April 2021.
What is the address of DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH?
The registered office of DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH is located at Egmontstraat 11, 1000 Brussel.
Is DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH still active?
Yes. According to the CBE (28 September 2026) DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH is active, legal situation “Normale toestand”, started on 9 April 2021.
Is DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH registered on Peppol?
Yes, DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH is registered on the Peppol network with ID 0208:0766541015.
What is the enterprise number of DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH?
The enterprise number of DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH is BE0766541015.
When was DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH founded?
DIGITAL INSTITUTE FOR CANCER OUTCOMES RESEARCH was founded on 9 April 2021.